Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2017 Jan 19.
Published in final edited form as: Biochemistry. 2016 Jan 5;55(2):277–286. doi: 10.1021/acs.biochem.5b01003

Substrate promotes productive gas binding in the αKG-dependent oxygenase FIH

Cornelius Y Taabazuing 1, Justin Fermann 1, Scott Garman 2, Michael J Knapp 1,*
PMCID: PMC4793777  NIHMSID: NIHMS764512  PMID: 26727884

Abstract

The Fe2+/αKG-dependent oxygenases use molecular oxygen to carry out a wide variety of reactions with important biological implications, such as DNA base-excision repair, histone demethylation, and the cellular hypoxia response. These enzymes follow a sequential mechanism in which O2 binds and reacts after the primary substrate binds, making those structural factors that promote productive O2 binding central to their chemistry. A large challenge in this field is to identify strategies that engender productive turnover. Factor Inhibiting HIF (FIH), is a Fe2+/αKG-dependent oxygenase that forms part of the O2 sensing machinery in human cells by hydroxylating the c-terminal transactivation domain (CTAD) found within the HIF-1α protein. The structure of FIH was solved with the O2 analogue NO bound to Fe, offering the first direct insight into the gas binding geometry in this enzyme. Through a combination of DFT calculations, {FeNO}7 EPR spectroscopy, and UV-Vis absorption spectroscopy we demonstrate that CTAD binding stimulates O2 reactivity by altering the orientation of the bound gas molecule. Although FIH binds NO with moderate affinity, the bound gas can adopt either of two orientations with similar stability; upon CTAD binding, NO adopts a single preferred orientation that is appropriate to support oxidative decarboxylation. Combined with other studies on related enzymes, our data suggests that substrate induced reorientation of bound O2 is the mechanism utilized by the αKG oxygenases to tightly couple O2 activation to substrate hydroxylation.

Introduction

The Fe2+/αKG-dependent oxygenases constitute the largest family of mononuclear nonheme oxygenases.1 These enzymes activate molecular oxygen (O2) and couple the oxidative decarboxylation of the αKG co-substrate to many important biological transformations, including repair of alkylated DNA and RNA, antibiotic synthesis, and protein modifications.25 Although these enzymes utilize a sequential mechanism in which primary substrate binding precedes O2 activation, thereby coupling O2 consumption to substrate hydroxylation, the mechanical linkage between these two steps remains elusive despite a number of studies testing the role of changes in Fe coordination number, 2° sphere contacts, and O2 affinity.59 The strategy by which coupled turnover is achieved is central to the normal function of these αKG-dependent oxygenases.

The Factor Inhibiting HIF (FIH) is an Fe2+/αKG-dependent enzyme that hydroxylates the HIF transcriptional activator specifically at Asn803 within the c-terminal transactivation domain (CTAD), regulating O2 homeostasis in human cells.10,11 A key feature of FIH function is that O2 activation is stimulated by the binding of the CTAD domain of the HIF transcription factor,12 which ensures that the rate of CTAD hydroxylation is directly proportional to the concentration of O2 (Scheme 1).1315 Recently, it was shown that CTAD binding leads to a mixture of 6-coordinate (6C) and 5-coordinate (5C) Fe2+ in FIH/CTAD,7 suggesting that greater O2 access to the Fe2+ may only partially explain the increased O2 reactivity upon CTAD binding. The rate-limiting step for O2 activation by FIH occurs before early in turnover, making FIH an excellent enzyme to interrogate the link between O2 activation and substrate hydroxylation in the broad class of αKG oxygenases.

Scheme 1.

Scheme 1

Proposed mechanism for FIH.

In order to gain insight into the structural factors that influence productive gas binding in the αKG oxygenases, we used NO as an O2 mimic to study the changes in the gas binding site of FIH induced by substrate binding. Nitric oxide (NO) is commonly used as an O2 surrogate to learn about intermediates and the chemistry of non heme O2 activating enzymes as bound NO adopts a similar geometry to that of O2.1618 NO is capable of reversibly binding to Fe2+ within enzyme active sites, altering the electronic properties to allow characterization by conventional EPR and electronic absorption spectroscopy.1921 Metal-nitrosyl complexes are generally described as {MNO}n, where n represents the sum of the metal d and NO π* electrons; Fe2+ bound NO is {FeNO}7.22

Although gas binding is crucial to defining the chemistry in non heme enzymes, little geometrical data exists. We are aware of only one structure of NO bound to an Fe2+/αKG-dependent oxygenase, clavaminate synthase (CAS).18 The structure of CAS with NO bound revealed a pseudo octahedral metal center with NO oriented above αKG in the presence of substrate.18 DFT calculations in a related enzyme, taurine dioxygenase (TauD), indicate that NO preferentially adopts two conformations, one in which the O-atom is directed towards αKG and another pointing over the active site carboxylate moeity.17 As only the conformation in which NO is oriented above αKG is expected to be reactive based on the consensus mechanism, factors governing the switch in NO orientation may be central to coupled turnover in αKG oxygenases.

Here we report our use of crystallography, electronic spectroscopy, and DFT calculations to test the role of substrate sterics on productive gas binding in FIH. CTAD binding, specifically the target residue (Asn803), was tested for its role in forming the proper gas binding geometry which leads to substrate hydroxylation. This is particularly important as evidence suggests that the gas binding geometry may be the fundamental process controlling turnover in the αKG-dependent oxygenases.

Materials and Methods

Protein Purification

Unless noted otherwise, all reagents were purchased and used as received from commercial vendors. FIH expression and purification was carried out as previously described.12,15 Briefly, the N-terminal His6 tagged protein was purified using a Ni-NTA column followed by removal of the tag via thrombin digestion. Post thrombin cleavage, three non-native residues (Gly, Ser, His) remain at the N-terminus of FIH. Exogenous metals were removed with EDTA treatment. FIH was further purified using size-exclusion chromatography to afford the active dimer. Protein concentrations were calculated by absorption spectroscopy (ε280 = 48800 M−1 cm−1).12

CTAD Purification

A 39 amino acid peptide substrate corresponding to the c- terminal transactivation domain of HIFα788–826 (CTAD) containing a Cys800 → Ala substitution with sequence DESGLPQLTSYDAEVNAPIQGSRNLLQGEELLRALDQVN (Asn803 in bold) was ordered from EZBiolabs as a desalted synthetic peptide with free N and C termini. Another 39 residue peptide also with a Cys800 → Ala point mutation containing the target residue Asn803 → Ala point mutation with sequence DESGLPQLTSYDAEVAAPIQGSRNLLQGEELLRALDQVN (Ala803 in bold) was also ordered from EZBiolabs as a desalted peptide with free N and C termini. The peptides were dissolved in 25% acetonitrile and purified by reverse-phase HPLC as previously reported.15 After two rounds of purification, the samples were >95% pure as determined using matrix assisted laser desorption ionization mass spectrometry (MALDI-MS). The concentrations were established by measuring the UV-absorption at 293 nm in 0.1 M NaOH (ε = 2400 M−1 cm−1).12

Crystallography and Data Refinement

Crystals of (Fe+NOG+NO)FIH were grown anaerobically using conditions similar to those previously reported in the literature.23 Crystals were grown in an anaerobic glovebox by the hanging drop vapor diffusion method by mixing 3 μL of a 20 mg/ml protein solution containing 0.55 mM FeSO4, and 2mM αKG in 50 mM Hepes pH 7.00 with 1 μL of the reservoir buffer containing 0.1 M Hepes, 1.2 M (NH4)2SO4, and 3 % polyethylene glycol (PEG) 400, pH 7.50. After setting up trays, the nitric oxide donor, Diethylammonium (Z)-1-(N,N-diethylamino)diazen-1-ium-1,2-diolate (DEANO) was added only to the reservoir solution to facilitate NO release into the headspace during crystallization. 100 μL of a 0.35 M stock of DEANO was added to the reservoir solutions (total volume = 500 μL), such that 70 mM DEANO was present, and the coverslips were quickly resealed. Crystals were allowed to grow in the glovebox at 23°C with NO filling the headspace in the wells. Yellow crystals grew within 4 days (Figure S2), at which time they were harvested on the bench top within 1 minute of the coverslip being flipped to minimize gas diffusion and flash frozen in reservoir solution containing 24% glycerol. Clear, colorless crystals of (Fe+αKG)FIH were grown anaerobically in the same fashion without the addition of DEANO to the reservoir solution.

Data was collected at the Advanced Photon Source facility in Chicago at 100 K using radiation of λ = 0.979 Å. 150 frames were collected at a crystal to detector distance of 345 mm with 1.5° oscillation and 1 second exposure per image for (Fe+NOG+NO)FIH. For (Fe+αKG)FIH, 150 frames were captured with 2° oscillations at a crystal to detector distance of 380 nm and 1 second exposure per image. The data sets were processed using iMOSFILM.24 Coordinates from PDB 3D8C23 were employed for molecular replacement using Phaser25 and the model building and refinement done using COOT26 and Refmac527 in the CCP428 software package. During refinement, 5% of the data was withheld and used to obtain an Rfree value. Data collection and crystallographic analysis statistics are reported in the supplementary material (Table S1). Anaerobic crystals of (Fe+αKG+NO)FIH, (Fe+αKG+NO)FIH/CTAD and (Fe+αKG+NOG+NO)FIH/CTAD were of poor quality and most dissolved during harvesting. Unfortunately the few that were successfully harvested failed to diffract well and we were unable to collect high resolution data.

Electronic Absorption Spectroscopy

For anaerobic experiments, stocks of FIH, αKG, NOG, and Hepes buffer were sealed with rubber septa and degassed with argon gas. FeSO4 was brought into the glovebox as a solid and prepared using degassed H2O while DEANO stocks were prepared in degassed 10 mM NaOH and the concentration verified by its published extinction coefficient and characteristic UV absorbance at 250 nm (ε250 = 6500 M−1cm−1).29,30 DEANO decomposes to form 1.5 equivalents31 of NO with a rate constant of 3.75 × 10−3 ± 8 × 10−5 s−1 under our conditions (Figure S1). Anaerobic UV-Vis samples contained FIH (0.25 mM), FeSO4 (0.25 mM), αKG (0.5 mM), CTAD (0.5 mM) and DEANO (0.13 – 2 mM) in 50mM Hepes pH 7.00. Samples were incubated in the glovebox at 23°C for 20 minutes to permit NO release and binding. The samples were capped and then UV-Vis absorption spectra were collected immediately after removal from the glovebox on an HP 8453 UV-Visible spectrophotometer from 300nm to 900nm in 1 cm path length quartz cuvettes. Data used to construct the binding isotherm is reported in the supplementary material (Figure S3). As FIH has comparable affinities for CTAD (KD = 80 μM) and N803A (KD = 180 μM),8 FIH was ~84% bound with CTAD and ~70% bound with the N803A substrate.32

EPR Spectroscopy

Anaerobic EPR samples containing FIH (0.10 mM), FeSO4, (0.10 mM), αKG (0.50mM), CTAD (0.50 mM), Asn803 → Ala peptide (0.50 mM) and DEANO (0.50 mM) in 50 mM Hepes pH 7.00 were prepared and aged anaerobically at 23°C for 20 minutes. The samples were capped then flash frozen in liquid nitrogen (LN2) immediately upon removal from the glovebox. X-Band EPR data was collected using a Bruker Elexsys E-500 EPR equipped with a DM4116 cavity and a Bruker ER 4118CF-O LHe/LN2 cryostat at 9.624 GHz frequency, 2.0mW power, 10G modulation amplitude, 100 GHz modulation frequency, 163 ms time constant at 4K.

The EPR data was analyzed by means of the standard spin Hamiltonian (HFe = β.B.g.S + S.D.S) where β is the Bohr magneton, B is the applied field, g is the electron Zeeman term, S is the electron spin operator, and D is the zero field splitting tensor. Simulations of the EPR spectra were calculated using the XSophe software package version 1.1.14.33 As the S = 3/2 {FeNO}7 spin is in the weak field limit (D≫hν), D was fixed at 10 cm−1, corresponding to the measured and calculated values of D for {FeNO}7 adducts of related enzymes 4-hydroxyphenylpyruvate dioxygenase (HPPD) (~ 8 cm−1) and TauD (~ 12 cm−1).16,17

DFT Calculations

Geometry optimizations were carried out on a truncated active site starting from the geometry of the crystal structure of FIH (PDB IH2L).34 Methyl imidazoles were used for His199 and His279, propionic acid for Asp201, 2 oxopropionate for αKG, and Asn803 was truncated and contained a methyl group from the adjacent amino acid (Figure 6). The {FeNO}7 S = 3/2 spin state was generated using the spin-coupling scheme of a high spin Fe3+ (SFe = 5/2) antiferromagnetically coupled to two electrons from the NO π* orbitals (SNO = 1) as this represents the proper electronic description of ferrous NO complexes.16,20 Using the geometry optimized structures, a rigid potential energy surface scan (B3LYP/6-311+g(2d,p)) was performed to investigate the energy barrier for rotating the bent NO ligand in the axial coordination position of FIH. The DFT calculations were completed with and without the target Asn803 residue in order to study the influence of the target residue on NO rotational barriers.

Figure 6.

Figure 6

Optimized geometries of A and B used in DFT calculations as models for FIH-{FeNO}7

Results

Crystal Structure of FIH in Complex with Fe and NO

To gain insight into the O2 binding site of FIH, we attempted to grow FIH bound to Fe2+, αKG, NO, and CTAD. Anaerobic crystals of (Fe+αKG+NO)FIH, (Fe+αKG+NO)FIH/CTAD and (Fe+αKG+NOG+NO)FIH/CTAD were of poor quality and most dissolved during harvesting. Unfortunately the few that were successfully harvested failed to diffract well and we were unable to collect high-resolution data. Good quality crystals grew for (Fe+αKG)FIH and (Fe+NOG+NO)FIH, which were harvested and sent for diffraction at Advanced Photon Source at Argonne National Laboratories. The structure of (Fe+αKG)FIH was refined to 2.4 Å with Rfactor = 20.0% and Rfree = 25% while the structure of the (Fe+NOG+NO)FIH complex was refined to 2.1 Å resolution (Rfactor = 19.0% and Rfree = 24%). For both (Fe+αKG)FIH and (Fe+NOG+NO)FIH, the active site metal retained pseudo octahedral geometry and Fe2+ was coordinated by His199, His279, Asp201 and αKG/NOG with the C1 carboxylate of αKG/NOG bound trans to His199 as previously reported for structures of (Fe+αKG)FIH35 and (Fe+NOG)FIH.34 The backbone of residues 9-349 were essentially unchanged upon binding NO. (rmsd = 0.153 Å) (Figure S4).36

For (Fe+αKG)FIH, the 2FoFc map displayed electron density at the coordination position trans to His279, indicating that the active site Fe of FIH was 6-coordinate as previously suggested by spectroscopic studies on FIH7 and other Fe2+/αKG oxygenases.9,37 The density was too small to accommodate a diatomic molecule such as O2 or two aquo ligands and refined best with one water molecule in this position (Figure 1A). Previously reported structures of (Fe+αKG)FIH at resolutions of 2.84 Å and 2.4 Å contained unresolved density above the metal centers which is likely to be due to water.34,35 Although the resolution of our structure was also modest (2.5 Å), the aquo ligand was reasonably well ordered with a refined B-factor of 46.0 Å2 and a reasonable Fe-OH2 bond length (2.00 Å). For comparison, the B-factors for the other atoms bonded to Fe were in the 36 – 40 Å2 range, with the exception of the very well ordered Asp201 O atom (26 Å2).

Figure 1.

Figure 1

Structure of (Fe+αKG)FIH and (Fe+NOG+NO)FIH. Iron is shown in magenta, water in red. (A) View of the (Fe+αKG)FIH active site with the 2FoFc map contoured to 1σ. (B) (Fe+NOG+NO)FIH active site and the 2FoFc map contoured to 1σ. (C) (Fe+NOG+NO)FIH active site with the Fo(Fe+NOG+NO)FIHFo(Fe+αKG)FIH map contoured to 1σ. (D) (Fe+NOG+NO)FIH active site measurements.

For (Fe+NOG+NO)FIH, the 2FoFc map displayed electron density at the diffusible ligand site above the metal center which was approximately twice the density observed in the (Fe+αKG)FIH structure. This density was consistent with the presence of a diatomic molecule as a single water molecule did not adequately refine into the density. Additionally, the FoFo difference Fourier map for the structure without NO subtracted from the structure with NO also displayed electron density at this site, the size and shape of which was consistent with a diatomic molecule (Figure 1C). We refined this as NO due to the size of the electron density, the spectroscopic data indicative of {FeNO}7 adduct formation in solution, and the yellow crystals that were used for X-ray diffraction.

The active site metal was pseudo octahedral with NO bound at the axial ligand site trans to His279, displacing water (Figure 1B). Although it cannot be interpreted from the density that NO ligated with the nitrogen atom, chemically, this is observed in model complexes and calculations.16,17,38 The Fe-N bond length (1.83 Å) and the Fe-N-O angle (133°) (Table 2), were within range of calculations and experimental data on Fe-N bond lengths (~1.70 Å – 1.88 Å) and Fe-N-O angles (~ 120° – 169°) for related enzymes and model complexes.1618,3840 The B-factors for NO were 50 Å2 for the N atom and 67 Å2 for the O atom, indicating that the N atom was reasonably well ordered while the O atom has greater disorder, as compared to the well-ordered N atoms on His199 (38 Å2) and His279 (37 Å2) in the (Fe+NOG+NO)FIH structure, further supporting our refinement of this density as an NO ligand. A partially resolved PEG molecule was bound above the NO ligand; as the active site of FIH is solvent exposed, the presence of PEG may speak to an evolutionary preference for peptide like constructs to be bound above the metal center. The structures of (Fe+αKG)FIH (PDB: 4Z2W) and (Fe+NOG+NO)FIH (PDB: 4Z1V) were deposited to the PDB and based on the PDB metrics (Clashscore, Sidechain outliers, Ramachandran outliers, etc.), they are amongst the most reliable structures of FIH that exist.

Table 2.

Comparison of Calculated and Experimental Geometric Parameters for {FeNO}7 centers in FIH and related enzymes

FIHa Ab Bc CASd HPPDe TauDf
ΔE(rotation) (kJ/mol) 147 5.4 9.4 f
Fe – N (Å) 1.83 1.85 1.83 1.79 1.76 1.88f (1.98)g
N – O (Å) 1.19 1.17 1.16 1.16 1.17 1.17f (1.19)g
Fe – N – O (deg) 133 143 156 146 149 144f (122)g
O1(αKG)-Fe – N – O (deg) 290 3 226 30
Fe – O(C1-O αKG) (Å) 2.02 2.01 2.03 2.01 2.06f
Fe – O(C2=O αKG) (Å) 2.15 2.35 2.32 2.27 2.37f
Fe – N(His199) (Å) 2.03 2.23 2.19 2.10
Fe – N(His279) (Å) 2.01 2.24 2.34 2.23
Fe – O(Asp201) (Å) 2.04 1.98 1.97 2.06
O(NO) – C2(αKG) (Å) 4.0 3.48 4.18 2.85
N(NO) – Fe – N(His279) (deg) 159 174 169 171
a

Measured from the (Fe+NOG+NO)FIH structure.

b

FIH-{FeNO}7 orientation A

c

FIH-{FeNO}7 orientation B.

d

Measured from PDB: 1GVG (reference 18). Values given correspond to residues in the same position as those for FIH.

e

Taken from reference 16.

f

Taken from reference 17.

g

Taken from reference 46 based on ESEEM data.

Electronic Absorption Spectroscopy

Formation of an {FeNO}7 center in the active site of a nonheme enzyme leads to moderately intense (ε < 1000 M−1 cm−1) absorption bands near 440 nm with a broad shoulder between 500 – 700 nm, arising from NO π* donor interaction into the Fe t2g orbtals.20,21,41 Addition of DEANO to (Fe+αKG)FIH led to a bright yellow solution with the expected electronic absorption bands (Figure 2) for an {FeNO}7 center.16,19,21,41,42 Upon addition of CTAD, the spectra increased in intensity, suggesting either tighter gas binding as proposed by the consensus mechanism or a geometric change resulting in stronger orbital overlap.

Figure 2.

Figure 2

Electronic absorption spectra of FIH (250 μM), FeSO4 (250 μM), αKG (500 μM), DEANO (2 mM) and CTAD or CTADN803A (500 μM) at 23°C in anaerobic Hepes (50 mM pH 7.00). Difference spectra were created by subtracting the spectrum of (Fe)FIH from each experimental spectrum.

A binding isotherm was constructed following the individual addition of aged DEANO solutions to premixed samples of (Fe+αKG)FIH (Figure S3) in order to test the effect of CTAD binding on gas-binding affinity of FIH. The dissociation constant (KD) for NO was obtained by fitting ΔA440 vs. [NO] to a saturation curve (equation 1) similar to previously reported for related extradiol dioxygenases42 and phenylalanine hydroxylase21 in which Amax represents the A440 at saturation.

ΔA=Amax[NO]KD+[NO] (1)

The samples were aged for 20 minutes (~7 half-lives) to allow NO release and binding, by which point the absorbance had ceased increasing. The NO affinity of (Fe+αKG)FIH was moderate (KD(NO) = 330 ± 25 μM) and increased slightly upon binding CTAD (KD(NO) = 200 ± 15 μM) (Table 1), indicating that CTAD did not promote gas binding significantly. In other αKG dependent oxygenases, a much more pronounced increase in NO affinity was observed in the presence of substrate, ranging from 5 – 100 fold.21,42

Table 1.

Summary of EPR Data and NO Dissociation Constants

sample experimental simulation

KD(NO) (μM) geff g tensors (g, g||) E/D
(Fe+NO+αKG)FIH/CTAD 200 ± 15 4.06, 4.00 2.015, 2.00 0.005
4.13, 3.91 2.015, 2.00 0.017
(Fe+NO+αKG)FIH/N803A 300 ± 30 4.10, 3.93 2.010, 2.00 0.014
(Fe+NO+αKG)FIH 330 ± 25 4.11, 3.92 2.010, 2.00 0.016
(Fe+NO) FIH ND 4.10, 3.93 2.010, 2.00 0.014

To test the effect of the steric and polar contacts created by the Asn803 target residue within CTAD on gas binding, we measured the NO affinity using a variant substrate containing the Asn803 → Ala point mutation (N803A). For the (Fe+αKG+NO)FIH/N803A complex, the KD(NO) = 300 ± 30 μM (Table 1), similar to the affinity for NO in the absence of CTAD (Figure 3). This indicated that the steric imposition of the Asn803 target residue did not overly affect the gas affinity in FIH.

Figure 3.

Figure 3

Binding isotherm of (Fe+NO+αKG)FIH, (Fe+NO+αKG)FIH/N803A and (Fe+NO+αKG)FIH/CTAD. FIH (0.25 mM), FeSO4 (0.24 mM), αKG (0.5 mM), CTAD (0.5 mM), N803A (0.5 mM) and DEANO (.013 – 2 mM).

Electron Paramagnetic Resonance Spectroscopy

Electron paramagnetic resonance (EPR) spectroscopy measurements were made after the addition of NO to samples of FIH in order to gain further insight into the geometry and electronic environment of the metal center. The electronic fine structure of {FeNO}7 is a sensitive reporter of geometric changes in the {FeNO}7 moeity, such as changes in the FeNO bond angle or oriientation.16,20,4245 The {FeNO}7 is an S = 3/2 spin system which is typically characterized by a large axial zero field splitting (E/D ~ 0) such that the Ms = ± 3/2 and ±1/2 Kramers doublets are well separated from each other. Due to the large zero field splitting (D ≫ hν) the EPR resonance arises solely from the lower doublet with effective g values at gx ≈ gy ≈ 4 and gz = 2.20,42 As the zero-field splitting becomes more rhombic (E/D > 0), the geff = 4 feature will split into two separate geff features.

Despite the modest increase in NO affinity in the presence of CTAD, we tested the impact of CTAD binding on the geometry of the {FeNO}7 moiety in FIH. Addition of NO to the FIH samples produced the expected yellow color and complex geff ~ 4 EPR line-shape (Figure 4), along with an S = 5/2 feature due to oxidation of Fe2+ to Fe3+ as seen in related nonheme {FeNO}7 sites.16,20,21,41,42

Figure 4.

Figure 4

Experimental and simulated X-Band EPR spectra of {FeNO}7 FIH complexes: (A) Spectra of (Fe+αKG+NO)FIH/CTAD, (Fe+αKG+NO)FIH/N803A, (Fe+αKG+NO)FIH, and (Fe+NO)FIH samples (B) Simulation of {FeNO}7 species. FIH (0.10mM), FeSO4 (0.10mM), αKG (0.50mM), CTAD (0.50mM), N803A (0.50mM), DEANO (0.50 mM), 9.624 GHz frequency, 2.0mW power, 10G modulation amplitude, 100 GHz modulation frequency, 163 ms time constant, 4K. (*) = Fe3+ with geff = 4.30, 4.25, present for all spectra.

The spectrum of (Fe+αKG+NO)FIH displayed a slightly rhombic S = 3/2 line-shape with geff = 4.11, 3.93 (E/D = 0.016) (Figure 4). Addition of NO to samples containing the native CTAD led to formation of (Fe+αKG+NO)FIH/CTAD which exhibited a highly axial line-shape with geff = 4.06, 4.00 (E/D = 0.005) (Figure 4), along with the slightly rhombic S = 3/2 species observed in the CTAD free complex. With the addition of NO to samples containing the N803A variant substrate, the (Fe+αKG+NO)FIH/N803A sample displayed a slightly rhombic electronic fine structure (E/D = 0.014, geff = 4.10, 3.93) as seen for the CTAD-free sample (Figure 4). This new axial line-shape corresponds to the active enzyme complex as CTAD contained the proper target residue, suggesting that the Fe-NO geometry changed upon binding the Asn803 target residue. The change in line-shape is indicative of a change in gas binding geometry, likely due to a rotational change as Solomon et al showed experimentally and computationally that the Fe-NO bond length and angle do not change to any appreciable degree in the presence of substrate for related enzyme HPPD.16

We simulated the three different species present in the spectra of the (Fe+NO+αKG)FIH/CTAD complex (Figure 4B) using XSophe.33 A summary of the simulation parameters and experimental geff values is shown in Table 1. The sum of the simulations overlaid well with the experimental spectra (Figure 4A), and showed that the spectra of (Fe+αKG+NO)FIH/CTAD consisted of two S = 3/2 species and one S = 5/2 species (Figure 4B). By comparing the experimental and simulated spectra, we observed that the highly axial S =3/2 signal with E/D = 0.005 is unique to CTAD bound FIH in which the proper target residue is present as the N803A substrate did not exhibit this line-shape.

DFT Calculations of FIH-{FeNO}7

In view of the {FeNO}7 EPR line-shape changes induced by CTAD binding, we turned to geometry optimization calculations to test the effect of the Asn803 target residue on the gas binding site in FIH. A truncated ligand set was used in the geometry optimization for structures corresponding to (Fe+NO+αKG)FIH and (Fe+NO+αKG)FIH/CTAD. The starting coordinates were taken from a crystal structure of FIH/CTAD,34 in which methyl terminated amino acid sidechains were used along with pyruvate in the place of αKG. Final geometry optimization employed an antiferromagnetic spin coupling between a high spin Fe3+ (S = 5/2) and NO (S = 1) to obtain an S=3/2 state, as this was shown to be the lowest energy electronic structure by prior workers.16,17,20 Following geometry optimization for each structure, the NO was rotated as a rigid body about the O1-Fe-N-O dihedral angle and the energy of each orientation was calculated.

A single minimum was found for (Fe+αKG+NO)FIH at a dihedral angle 226° (Figure 5), however the entire energy surface was relatively independent of dihedral angle with all orientations within 5 kJ/mol of this minimum. In the minimum energy structure, NO was pointed between the π-acceptor groups of His199 and the C2 keto of αKG (Figure 6), similar to the orientation observed for the TauD-{FeNO}7 complex17 and very close to that observed in our crystallographic refinement of the (Fe+NOG+NO)FIH. Our calculated Fe-N bond length was 1.83 Å and the Fe-N-O angle was 156° (Table 2). These calculated bond metrics were in good agreement with those reported for the (Fe+NO+αKG)TauD based on calculations17 and ESEEM data, 46,47 as is the low rotational barrier about the Fe-N axis.17

Figure 5.

Figure 5

Rigid scanned potential energy surface for rotation about the O1-Fe-NO axis in the FIH-{FeNO}7 complex.

In the energy minimized structure corresponding to FIH/CTAD, a single energy minimum was found in which the O1-Fe-N-O dihedral angle was 3° (Figure 5), similar to that found in the crystal structure of NO bound to CAS.18 This placed the bound NO directly above the O1. The energetic barrier for NO rotation about the Fe-N bond vector was quite large (147 kJ/mol), indicating that the sterics of the Asn803 sidechain greatly outweighed electronic factors in orienting the bound gas molecule. As O2 is isosteric with NO, it is very likely that sterics will place the bound O2 into a similar orientation en route to oxidative decarboxylation.

The presence of Asn803 led to nearly unchanged {FeNO}7 bonding metrics between the geometry optimized structures, with the exception of the O1-Fe-NO dihedral angle. As a consequence, the distance between the Cketo and the distal O of NO decreased in the structure corresponding to FIH/CTAD (3.48 Å) relative to the structure corresponding to FIH (4.18 Å). This suggests that the steric environment created by the Asn803 target residue will play a significant role in directing O2 to react at the keto position during normal turnover.

Discussion

A number of mechanistic and spectroscopic studies have been undertaken to study the substrate stimulated O2 activation by αKG-dependent oxygenase,13,17,4854 leading to the view that substrate binding primes the enzyme to react with O2 to form the ferryl intermediate. In light of the fact that primary substrate does not bind directly to Fe2+, and the observation that contacts throughout the active site greatly impact reactivity,15,55 it appears that substrate binding alters the steric and non-covalent contacts near the gas binding site to stimulate O2 activation. Understanding factors governing O2 binding are key to understanding why the ferryl forms preferentially after the primary substrate is in position for subsequent hydroxylation. The present study integrated spectroscopic, computational, and crystallographic analysis to test the linkage between CTAD binding and NO binding in FIH as a mimic for O2 binding. Our crystallographic refinement of the (Fe+NOG+NO)FIH structure offers new insight into O2 binding, as this is only the second structure reported for an enzyme from the Fe/αKG oxygenase superfamily bound to NO. Our data suggests that the target residue (CTAD-Asn803) plays a pivotal role in directing O2 reactivity by providing steric constraints that orient O2 for oxidative decarboxylation, resulting in coupled turnover in FIH.

The current dominant model to explain O2 activation and coupled turnover in the αKG-dependent oxygenases is centered on the idea that O2 reacts at a vacant coordination site that is present only when both αKG and substrate are present.3 O2 is thought to become reactive as a superoxo radical anion (O2) upon binding the 5-coordinate Fe center, but no direct evidence of this has been established for the Fe/αKG oxygenase family. Electronic spectroscopy of Fe/αKG oxygenases and related His2Asp facial triad-containing enzymes reveal that the Fe2+ center typically converts from a 6-coordinate to a 5-coordinate geometry upon binding primary substrate,3,37,56 implying that creation of an open coordination site is the origin of the increased NO/O2 affinity for these enzymes. In contrast, CTAD binding to FIH creates an Fe2+ center that is a mixture of 5- and 6-coordinate geometries,7 suggesting that an open coordination site only partially explains the increased reactivity.

In order for oxidative decarboxylation to occur, the consensus mechanism for Fe/αKG oxygenases relies on the ferric superoxide attacking the C2-keto position of αKG. Although the Fe3+(O2) intermediate has never been observed for any αKG oxygenase, its existence in this class of enzyme is supported by computational predictions,16,38,57,58 the observation of {FeNO}7 adducts,17 and the observation of such an intermediate in homoprotochatechuate 2,3-dioxygenase, an extradiol dioxygenase.59 Our EPR and UV-Vis spectroscopic data showed that NO bound to the Fe2+ center of FIH, forming a typical non-heme {FeNO}7, while the bonding metrics found in the crystallographic structure of the {FeNO}7 center of FIH were similar to those reported for TauD, CAS, and the oxo-acid oxygenase HPPD. This indicated that the gas binding center of FIH was comparable to these other oxygenases, despite the O2-sensing role of FIH.

The backbone and sidechains of FIH were nearly superimposable for the (Fe+αKG)FIH and (Fe+NOG+NO)FIH structures, indicating that only minor alterations in contacts were needed for NO binding. Similarly, slight shifts in nearby residues accommodated substrate and NO binding in the oxygen binding cavity in the extradiol dioxygenase BphC.39 In contrast to the orientation of NO found in CAS, where NO pointed toward αKG,18 the (Fe+NO+NOG)FIH structure showed NO oriented away from the active site carboxylate towards the most accessible site near His199. There was a water molecule above NO that appeared to play a stabilizing role for the bound gas orientation. The energetic penalty for reorientation would be approximately equal to the bond dissociation energy to break a typical hydrogen bond, roughly 25 kJ/mol.60 The previously published structure of FIH with bound CTAD34 showed that the CTAD-Asn803 target residue occupied the same region of the active site that was occupied by PEG and the water molecule in our (Fe+NO+NOG)FIH structure, suggesting that CTAD displaces any stabilizing contacts to the bound gas. In addition, the most accessible site in the gas binding pocket after CTAD binding rests directly over αKG, suggesting that steric occlusion of bound gas due to the presence of Asn803 plays a role in directing nucleophilic attack on the C2-keto position of αKG.

Remarkably, the impact of binding primary substrate on gas affinity was very small for FIH. Nonheme Fe2+ oxygenases typically bind NO with a moderate affinity (KD ~ 200 μM)21,42 which then becomes significantly higher after binding primary substrate. For example, upon substrate binding phenylalanine hydroxylase exhibited nearly a 5 fold increase in gas binding affinity (KD(NO) = 31 μM with substrate)21 while protocatechuate 4,5-dioxygenase exhibited a 100-fold increase in NO affinity (KD(NO) = 3 μM with substrate).42 In contrast, upon substrate binding FIH/CTAD has an unusually small increase in NO affinity (KD(NO) = 200 μM with substrate) (Table 1), suggesting that gas access to the coordination site on Fe is nearly independent of CTAD binding. The weak affinity of FIH/CTAD for NO is mirrored by its relatively low Michaelis constant toward O2,8,61 both of which indicate that CTAD binding does not stimulate diatomic gas binding. This in turn strongly suggests that oxygenation by FIH is not stimulated by a change in gas affinity, raising the potential for factors other than access to an open Fe coordination site to govern coupling between oxidative decarboxylation and substrate hydroxylation.

The spectroscopically characterized Fe3+(O2) intermediate in homoprotochatechuate 2,3-dioxygenase provides intriguing clues as to the effect of altered local contacts on reactivity in αKG oxygenases. In WT homoprotochatechuate 2,3-dioxygenase, the initially formed Fe3+(O2) rapidly undergoes electron transfer with the coordinated catechol substrate to form the reactive Fe2+(O2) + semiquinone intermediate en route to forming product.59,62 However, a single point mutation and the use of an electron withdrawing 4-nitrocatechol substrate permits accumulation of the Fe3+(O2) on the seconds timescale,59 underscoring how subtle changes in active site contacts can impact oxygenase reactivity.

The active site of FIH changes upon binding CTAD, leading to a number of altered contacts near the gas binding site. We observed changes in the {FeNO}7 EPR lineshape of (Fe+αKG+NO)FIH upon binding CTAD, which we attribute to changes in the orientation of the bound NO based on the geometry optimization calculations. Although the EPR lineshape is complex, the dominant S=3/2 species changes from a slightly rhombic species (E/D = 0.016) to a highly axial species (E/D = 0.005) upon binding CTAD. As the E/D ratio reflects overlap between the NO πip* and πop* orbitals and the Fe t2g orbitals, rotation about the Fe-NO bond vector will alter the EPR line-shape due to changes in the overlap of these π-symmetry orbitals. Our geometry optimization calculations predict a large barrier to rotation about the O1-Fe-NO dihedral angle in FIH/CTAD, which agrees with the observation that the highly axial {FeNO}7 EPR line-shape was not induced by the less bulky Asn803 → Ala variant CTAD. Consequently, we attribute the more axial (E/D = 0.005) EPR line-shape in FIH/CTAD to a CTAD-induced change in the gas orientation.

Similar variations in the {FeNO}7 EPR line-shape have been attributed to conformational changes in other nonheme Fe2+ enzymes. DFT calculations showed that NO adopted at least 2 conformations in TauD,17 implying that O2 reactivity in TauD could vary in response to the distribution between multiple conformers. The EPR spectra for protocatechuate 4,5-dioxygenase and homoprotochatechuate 2,3-dioxygenase showed the presence of multiple S = 3/2 species, attributed to pH-dependent protein conformational changes.42 Although it is not obvious how the altered electronic structure of {FeNO}7 translates into the reactivity of the {FeO2}8 intermediate formed during normal turnover, the oxidative decarboxylation step is likely to require proximity between the distal O-atom of bound superoxide and the keto position of αKG.

We propose that CTAD binding induces oxidative decarboxylation in FIH by restricting the conformational freedom of bound O2 such that it is lined up for reaction with αKG. This follows from our calculations showing that in the presence of Asn803, NO adopted a conformation in which it was positioned near the keto group of αKG (Figure 6), consistent with the observed orientation of NO in substrate bound CAS,18 suggesting that this orientation may depict the preferred gas orientation in the αKG-dependent oxygenases following substrate binding.

Conclusion

The key feature of the consensus mechanism for αKG oxygenases is the coupling of O2 reactivity to the presence of primary substrate. Although this is commonly attributed to the creation of an open coordination site on the Fe(II), our results for FIH indicate that such a view is incomplete. In particular, the affinity of FIH for NO, an excellent mimic of O2, is essentially unchanged by CTAD binding. Taken together, the spectroscopic, structural, and computational data support reorientation of bound gas as a mechanistic strategy employed by FIH to couple O2 reactivity to primary substrate binding. This raises the intriguing possibility that sterics within the active site directs O2 activation in FIH, and may play a similar role in other αKG oxygenases.

Supplementary Material

Supplemental Information

Acknowledgments

We thank the NIH (GM077413), and UMass CBI program (5T32GM008515-17) for funding, and the NSF (CHE-0443180 NSF-CRIF) for support of the EPR facility. We thank Jeanne A. Hardy and Scott J. Eron for support of the crystallography on this project. We also thank Kay Perry at beamline 24- ID-C at the Advanced Photon Source at Argonne National Laboratories for assisting us with remote collection. These crystallographic data were collected at the Advanced Photon Source on the Northeastern Collaborative Access Team beamline 24-ID-C, which is supported by a grant from the National Institute of General Medical Sciences (P41 GM103403) from the National Institutes of Health. This research used resources of the Advanced Photon Source, a U.S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract No. DE-AC02-06CH11357.

List of Abbreviated Terms

CAS

Clavaminate synthase

CTAD

C-terminal transactivation domain, of HIF-1α

DEANO

Diethylammonium (Z)-1-(N,N-diethylamino)diazen-1-ium-1,2-diolate

FIH

Factor Inhibiting HIF

HIF

Hypoxia Inducible Factor

HPPD

4-Hydroxyphenylpyruvate dioxygenase

NOG

N-oxalylglycine

TauD

Taurine dioxygenase

αKG

α-ketoglutarate

References

  • 1.Que L, Ho RYN. Dioxygen Activation by Enzymes with Mononuclear Non-Heme Iron Active Sites. Chem Rev. 1996;96:2607–2624. doi: 10.1021/cr960039f. [DOI] [PubMed] [Google Scholar]
  • 2.Hausinger RP. Fe(II)/alpha-Ketoglutarate-Dependent Hydroxylases and Related Enzymes. Crit Rev Biochem Mol Biol. 2004;39:21–68. doi: 10.1080/10409230490440541. [DOI] [PubMed] [Google Scholar]
  • 3.Solomon EI, Brunold TC, Davis MI, Kemsley JN, Lee SK, Lehnert N, Neese F, Skulan AJ, Yang YS, Zhou J. Geometric and Electronic Structure/function Correlations in Non-Heme Iron Enzymes. Chem Rev. 2000;100:235–349. doi: 10.1021/cr9900275. [DOI] [PubMed] [Google Scholar]
  • 4.Costas M, Mehn MP, Jensen MP, Que L. Dioxygen Activation at Mononuclear Nonheme Iron Active Sites: Enzymes, Models, and Intermediates. Chem Rev. 2004;104:939–986. doi: 10.1021/cr020628n. [DOI] [PubMed] [Google Scholar]
  • 5.Hangasky JA, Valleiere MA, Knapp MJ, CYT Imposing Function down a (cupin)-Barrel: Secodary Structure and Metal Stereochemistry in the αKG-Depenedent Oxygenases. Metallomics. 2012 doi: 10.1039/c3mt20153h. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Ehrismann D, Flashman E, Genn DN, Mathioudakis N, Hewitson KS, Ratcliffe PJ, Schofield CJ. Studies on the Activity of the Hypoxia-Inducible-Factor Hydroxylases Using an Oxygen Consumption Assay. Biochem J. 2007;401:227–234. doi: 10.1042/BJ20061151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Light KM, Hangasky JA, Knapp MJ, Solomon EI. Spectroscopic Studies of the Mononuclear Non-Heme Fe(II) Enzyme FIH: Second-Sphere Contributions to Reactivity. J Am Chem Soc. 2013;135:9665–9674. doi: 10.1021/ja312571m. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Hangasky JA, Ivison T, Knapp MJ. Substrate Positioning by Gln 239 Stimulates Turnover in Factor Inhibiting HIF, an αKG-Dependent Hydroxylase. Biochemis. 2014;53:5750–5758. doi: 10.1021/bi500703s. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Pavel EG, Kitajima N, Solomon EI. Magnetic Circular Dichroism Spectroscopic Studies of Mononuclear Non-Heme Ferrous Model Complexes. Correlation of Excited- and Ground-State Electronic Structure with Geometry. J Am Chem Soc. 1998;120:3949–3962. [Google Scholar]
  • 10.Lando D, Peet DJ, Gorman JJ, Whelan DA, Whitelaw ML, Bruick RK. FIH-1 Is an Asparaginyl Hydroxylase Enzyme That Regulates the Transcriptional Activity of Hypoxia-Inducible Factor. Genes Dev. 2002;16:1466–1471. doi: 10.1101/gad.991402. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Semenza GL. Regulation of Oxygen Homeostasis by Hypoxia-Inducible Factor 1. Physiology. 2009;24:97–106. doi: 10.1152/physiol.00045.2008. [DOI] [PubMed] [Google Scholar]
  • 12.Chen YH, Comeaux LM, Herbst RW, Saban E, Kennedy DC, Maroney MJ, Knapp MJ. Coordination Changes and Auto-Hydroxylation of FIH-1: Uncoupled O(2)-Activation in a Human Hypoxia Sensor. J Inorg Biochem. 2008;102:2120–2129. doi: 10.1016/j.jinorgbio.2008.07.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Hangasky JA, Saban E, Knapp MJ. Inverse Solvent Isotope Effects Arising from Substrate Triggering in the Factor Inhibiting Hypoxia Inducible Factor. Biochemistry. 2013;52:1594–1602. doi: 10.1021/bi3015482. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Mantri M, Zhang Z, McDonough MA, Schofield CJ. Autocatalysed Oxidative Modifications to 2-Oxoglutarate Dependent Oxygenases. Febs J. 279:1563–1575. doi: 10.1111/j.1742-4658.2012.08496.x. [DOI] [PubMed] [Google Scholar]
  • 15.Saban E, Chen YHA, Hangasky JY, Taabazuing C, Holmes BE, Knapp MJ. The Second Coordination Sphere of FIH Controls Hydroxylation. Biochemistry. 2011;50:4733–4740. doi: 10.1021/bi102042t. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Diebold AR, Brown-Marshall CD, Neidig ML, Brownlee JM, Moran GR, Solomon EI. Activation of Alpha-Keto Acid-Dependent Dioxygenases: Application of an {FeNO}(7)/{FeO2}(8) Methodology for Characterizing the Initial Steps of O-2 Activation. J Am Chem Soc. 2011;133:18148–18160. doi: 10.1021/ja202549q. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Ye S, Price JC, Barr EW, Green MT, Bollinger JM, Jr, Krebs C, Neese F. Cryoreduction of the NO-Adduct of Taurine:alpha-Ketoglutarate Dioxygenase (TauD) Yields an Elusive {FeNO}(8) Species. J Am Chem Soc. 2010;132:4739–4751. doi: 10.1021/ja909715g. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Zhang Z, Ren JS, Harlos K, McKinnon CH, Clifton IJ, Schofield CJ. Crystal Structure of a Clavaminate Synthase-Fe(II)-2-Oxoglutarate-Substrate-NO Complex: Evidence for Metal Centred Rearrangements. FEBS Lett. 2002;517:7–12. doi: 10.1016/s0014-5793(02)02520-6. [DOI] [PubMed] [Google Scholar]
  • 19.Copik AJ, Waterson S, Swierczek SI, Bennett B, Holz RC. Both Nucleophile and Substrate Bind to the Catalytic Fe(II)-Center in the Type-II Methionyl Aminopeptidase from Pyrococcus Furiosus. Inorg Chem. 2005;44:1160–1162. doi: 10.1021/ic0487934. [DOI] [PubMed] [Google Scholar]
  • 20.Brown CA, Pavlosky MA, Westre TE, Zhang Y, Hedman B, Hodgson KO, Solomon EI. Spectroscopic and Theoretical Description of the Electronic Structure of S = 3/2 Iron-Nitrosyl Complexes and Their Relation to O2 Activation by Non-Heme Iron Enzyme Active Sites. J Am Chem Soc. 1995;117:715–732. [Google Scholar]
  • 21.Han AY, Lee AQ, Abu-Omar MM. EPR and UV-Vis Studies of the Nitric Oxide Adducts of Bacterial Phenylalanine Hydroxylase: Effects of Cofactor and Substrate on the Iron Environment. Inorg Chem. 2006;45:4277–4283. doi: 10.1021/ic060478p. [DOI] [PubMed] [Google Scholar]
  • 22.Enemark JH, Feltham RD. Principles of Structure, Bonding, and Reactivity for Metal Nitrosyl Complexes. Coord Chem Rev. 1974;13:339–406. [Google Scholar]
  • 23.Hewitson KS, Holmes SL, Ehrismann D, Hardy AP, Chowdhury R, Schofield CJ, McDonough Ma. Evidence That Two Enzyme-Derived Histidine Ligands Are Sufficient for Iron Binding and Catalysis by Factor Inhibiting HIF (FIH) J Biol Chem. 2008;283:25971–25978. doi: 10.1074/jbc.M804999200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Battye TGG, Kontogiannis L, Johnson O, Powell HR, Leslie AGW. iMOSFLM: A New Graphical Interface for Diffraction-Image Processing with MOSFLM. Acta Crystallogr Sect D Biol Crystallogr. 2011;67:271–281. doi: 10.1107/S0907444910048675. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.McCoy AJ, Grosse-Kunstleve RW, Adams PD, Winn MD, Storoni LC, Read RJ. Phaser Crystallographic Software. J Appl Crystallogr. 2007;40:658–674. doi: 10.1107/S0021889807021206. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Emsley P, Cowtan K. Coot: Model-Building Tools for Molecular Graphics. Acta Crystallogr Sect D Biol Crystallogr. 2004;60:2126–2132. doi: 10.1107/S0907444904019158. [DOI] [PubMed] [Google Scholar]
  • 27.Murshudov GN, Skubák P, Lebedev Aa, Pannu NS, Steiner Ra, Nicholls Ra, Winn MD, Long F, Vagin Aa. REFMAC5 for the Refinement of Macromolecular Crystal Structures. Acta Crystallogr Sect D Biol Crystallogr. 2011;67:355–367. doi: 10.1107/S0907444911001314. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Project CC. The CCP4 Suite: Programs for Protein Crystallography. Acta Crystallogr Sect D Biol Crystallogr. 1994;50:760–763. doi: 10.1107/S0907444994003112. [DOI] [PubMed] [Google Scholar]
  • 29.Maragos CM, Morley D, Wink DA, Dunams TM, Saavedra JE, Hoffman A, Bove AA, Isaac L, Hrabie JA, Keefer LK. Complexes of NO with Nucleophiles as Agents for the Controlled Biological Release of Nitric-Oxide-Vasorelaxant Effects. J Med Chem. 1991;34:3242–3247. doi: 10.1021/jm00115a013. [DOI] [PubMed] [Google Scholar]
  • 30.Keefer LK, Nims RW, Davies KM, Wink DA. NONOates” (1-Substituted Diazen-1-Ium-1,2-Diolates) as Nitric Oxide Donors: Convenient Nitric Oxide Dosage Forms. Meth Enzym. 1996;268:281–293. doi: 10.1016/s0076-6879(96)68030-6. [DOI] [PubMed] [Google Scholar]
  • 31.Keefer LK, Nims RW, Davies KM, Wink DA. NONOates” (1-Substituted Diazen-1-Ium-1,2-Diolates) as Nitric Oxide Donors: Convenient Nitric Oxide Dosage Forms. Nitric Oxide, Pt a - Sources Detect No; No Synthase. 1996;268:281–293. doi: 10.1016/s0076-6879(96)68030-6. [DOI] [PubMed] [Google Scholar]
  • 32.Ramírez-Tapia LE, Martin CT. New Insights into the Mechanism of Initial Transcription: The T7 RNA Polymerase Mutant p266l Transitions to Elongation at Longer RNA Lengths than Wild Type. J Biol Chem. 2012;287:37352–37361. doi: 10.1074/jbc.M112.370643. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Hanson GR, Gates KE, Noble CJ, Griffin M, Mitchell A, Benson S. XSophe-Sophe-XeprView (R). A Computer Simulation Software Suite (v. 1.1.3) for the Analysis of Continuous Wave EPR Spectra. J Inorg Biochem. 2004;98:903–916. doi: 10.1016/j.jinorgbio.2004.02.003. [DOI] [PubMed] [Google Scholar]
  • 34.Elkins JM, Hewitson KS, McNeill LA, Seibel JF, Schlemminger I, Pugh CW, Ratcliffe PJ, Schofield CJ. Structure of Factor-Inhibiting Hypoxia-Inducible Factor (HIF) Reveals Mechanism of Oxidative Modification of HIF-1 Alpha. J Biol Chem. 2003;278:1802–1806. doi: 10.1074/jbc.C200644200. [DOI] [PubMed] [Google Scholar]
  • 35.Dann CE, Bruick RK, Deisenhofer J. Structure of Factor-Inhibiting Hypoxia-Inducible Factor 1: An Asparaginyl Hydroxylase Involved in the Hypoxic Response Pathway. Proc Natl Acad Sci U S A. 2002;99:15351–15356. doi: 10.1073/pnas.202614999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Rother K. Introduction to PyMOL. Methods Mol Biol Clift Nj. 2005;635:0–32. [Google Scholar]
  • 37.Pavel EG, Zhou J, Busby RW, Gunsior M, Townsend CA, Solomon EI. Circular Dichroism and Magnetic Circular Dichroism Spectroscopic Studies of the Non-Heme Ferrous Active Site in Clavaminate Synthase and Its Interaction with Alpha-Ketoglutarate Cosubstrate. J Am Chem Soc. 1998;120:743–753. [Google Scholar]
  • 38.Schenk G, Pau MYM, Solomon EI. Comparison between the Geometric and Electronic Structures and Reactivities of {FeNO}7 and {FeO2}8 Complexes: A Density Functional Theory Study. J Am Chem Soc. 2004;126:505–515. doi: 10.1021/ja036715u. [DOI] [PubMed] [Google Scholar]
  • 39.Sato N, Uragami Y, Nishizaki T, Takahashi Y, Sazaki G, Sugimoto K, Nonaka T, Masai E, Fukuda M, Senda T. Crystal Structures of the Reaction Intermediate and Its Homologue of an Extradiol-Cleaving Catecholic Dioxygenase. J Mol Biol. 2002;321:621–636. doi: 10.1016/s0022-2836(02)00673-3. [DOI] [PubMed] [Google Scholar]
  • 40.Roach PL, Clifton IJ, Hensgens CMH, Shibata N, Schofield CJ, Hajdu J, Baldwin JE. Structure of Isopenicillin N Synthase Complexed with Substrate and the Mechanism of Penicillin Formation. Nature. 1997;387:827–830. doi: 10.1038/42990. [DOI] [PubMed] [Google Scholar]
  • 41.Hegg EL, Whiting AK, Saari RE, McCracken J, Hausinger RP, Que L. Herbicide-Degrading Alpha-Keto Acid-Dependent Enzyme TfdA: Metal Coordination Environment and Mechanistic Insights. Biochemistry. 1999;38:16714–16726. doi: 10.1021/bi991796l. [DOI] [PubMed] [Google Scholar]
  • 42.Arciero DM, Orville aM, Lipscomb JD. [17O]Water and Nitric Oxide Binding by Protocatechuate 4, 5-Dioxygenase Catechol 2, 3-Dioxygenase. Evidence for Binding of Exogenous Ligands to the Active Site Fe2+ of Extradiol Dioxygenases. J Biol Chem. 1985;260:14035–14044. [PubMed] [Google Scholar]
  • 43.Arciero DM, Lipscomb JD, Huynh BH, Kent TA, Munck E. EPR and Mossbauer Studies of Protocatechuate 4,5-Dioxygenase. Characterization of a New Fe2+ Environment. J Biol Chem. 1983;258:14981–14991. [PubMed] [Google Scholar]
  • 44.Orville aM, Chen VJ, Kriauciunas a, Harpel MR, Fox BG, Münck E, Lipscomb JD. Thiolate Ligation of the Active Site Fe2+ of Isopenicillin N Synthase Derives from Substrate rather than Endogenous Cysteine: Spectroscopic Studies of Site-Specific Cys----Ser Mutated Enzymes. Biochemistry. 1992;31:4602–4612. doi: 10.1021/bi00134a010. [DOI] [PubMed] [Google Scholar]
  • 45.Orville AM, Lipscomb JD. Simultaneous Binding of Nitric Oxide and Isotopically Labeled Substrates or Inhibitors by Reduced Protocatechuate 3,4-Dioxygenase. J Biol Chem. 1993;268:8596–8607. [PubMed] [Google Scholar]
  • 46.Muthukumaran RB, Grzyska PK, Hausinger RP, McCracken J. Probing the Iron-Substrate Orientation for Taurine/alpha-Ketoglutarate Dioxygenase Using Deuterium Electron Spin Echo Envelope Modulation Spectroscopy. Biochemistry. 2007;46:5951–5959. doi: 10.1021/bi700562t. [DOI] [PubMed] [Google Scholar]
  • 47.Casey TM, Grzyska PK, Hausinger RP, McCracken J. Measuring the Orientation of Taurine in the Active Site of the Non-Heme Fe(II)/α-Ketoglutarate-Dependent Taurine Hydroxylase (TauD) Using Electron Spin Echo Envelope Modulation (ESEEM) Spectroscopy. J Phys Chem B. 2013;117:10384–10394. doi: 10.1021/jp404743d. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Flagg SC, Giri N, Pektas S, Maroney MJ, Knapp MJ. Inverse Solvent Isotope Effects Demonstrate Slow Aquo Release from Hypoxia Inducible Factor-Prolyl Hydroxylase (PHD2) Biochemistry. 2012;51:6654–6666. doi: 10.1021/bi300229y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Saban E, Flagg SC, Knapp MJ. Uncoupled O-2-Activation in the Human HIF-Asparaginyl Hydroxylase, FIH, Does Not Produce Reactive Oxygen Species. J Inorg Biochem. 2011;105:630–636. doi: 10.1016/j.jinorgbio.2011.01.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.McCusker KP, Klinman JP. Modular Behavior of tauD Provides Insight into the Origin of Specificity in Alpha-Ketoglutarate-Dependent Nonheme Iron Oxygenases. Proc Natl Acad Sci U S A. 2009;106:19791–19795. doi: 10.1073/pnas.0910660106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Ye S, Riplinger C, Hansen A, Krebs C, Bollinger JM, Neese F. Electronic Structure Analysis of the Oxygen-Activation Mechanism by Fe II- and A-Ketoglutarate (αKG)-Dependent Dioxygenases. Chem - A Eur J. 2012;18:6555–6567. doi: 10.1002/chem.201102829. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Flashman E, Hoffart LM, Hamed RB, Bollinger JM, Jr, Krebs C, Schofield CJ. Evidence for the Slow Reaction of Hypoxia-Inducible Factor Prolyl Hydroxylase 2 with Oxygen. FEBS J. 2010;277:4089–4099. doi: 10.1111/j.1742-4658.2010.07804.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Price JC, Barr EW, Hoffart LM, Krebs C, Bollinger JM. Kinetic Dissection of the Catalytic Mechanism of Taurine: Alpha-Ketoglutarate Dioxygenase (TauD) from Escherichia Coli. Biochemistry. 2005;44:8138–8147. doi: 10.1021/bi050227c. [DOI] [PubMed] [Google Scholar]
  • 54.Bollinger JM, Price JC, Hoffart LM, Barr EW, Krebs C. Mechanism of Taurine: Alpha-Ketoglutarate Dioxygenase (TauD) from Escherichia Coli. Eur J Inorg Chem. 2005:4245–4254. doi: 10.1021/bi050227c. [DOI] [PubMed] [Google Scholar]
  • 55.Pektas S, Knapp MJ. Substrate Preference of the HIF-Prolyl Hydroxylase-2 (PHD2) and Substrate-Induced Conformational Change. J Inorg Biochem. 2013;126:55–60. doi: 10.1016/j.jinorgbio.2013.05.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Solomon EI, Decker A, Lehnert N. Non-Heme Iron Enzymes: Contrasts to Heme Catalysis. Proc Natl Acad Sci U S A. 2003;100:3589–3594. doi: 10.1073/pnas.0336792100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Brown CD, Neidig ML, Neibergall MB, Lipscomb JD, Solomon EI. VTVH-MCD and DFT Studies of Thiolate Bonding to {FeNO}7/{FeO2}8 Complexes of Isopenicillin N Synthase: Substrate Determination of Oxidase versus Oxygenase Activity in Nonheme Fe Enzymes. J Am Chem Soc. 2007;129:7427–7438. doi: 10.1021/ja071364v. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Chen H, Cho K, Bin, Lai W, Nam W, Shaik S. Dioxygen Activation by a Non-Heme iron(II) Complex: Theoretical Study toward Understanding Ferric-Superoxo Complexes. J Chem Theory Comput. 2012;8:915–926. doi: 10.1021/ct300015y. [DOI] [PubMed] [Google Scholar]
  • 59.Mbughuni MM, Chakrabarti M, Hayden JA, Bominaar EL, Hendrich MP, Muenck E, Lipscomb JD. Trapping and Spectroscopic Characterization of an Fe-III-Superoxo Intermediate from a Nonheme Mononuclear Iron-Containing Enzyme. Proc Natl Acad Sci U S A. 2010;107:16788–16793. doi: 10.1073/pnas.1010015107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Nelson DL, Cox MM. Lehninger Principles of Biochemistry. 4. 2004. [Google Scholar]
  • 61.Koivunen P, Hirsila M, Gunzler V, Kivirikko KI, Myllyharju J. Catalytic Properties of the Asparaginyl Hydroxylase (FIH) in the Oxygen Sensing Pathway Are Distinct from Those of Its Prolyl 4-Hydroxylases. J Biol Chem. 2004;279:9899–9904. doi: 10.1074/jbc.M312254200. [DOI] [PubMed] [Google Scholar]
  • 62.Lipscomb EGK, Crystal JD. Structures of Fe2+ Dioxygenase Superoxo, Alkylperoxo, and Bound Product Intermediates. Science (80-) 2007;316:453–457. doi: 10.1126/science.1134697. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplemental Information

RESOURCES